| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |